Last updated: February 22, 2026
What is the scope of patent JP2016512455?
Patent JP2016512455 pertains to a pharmaceutical composition or method related to a specific drug or therapeutic use. This patent primarily covers:
- Subject Matter: The patent describes a pharmaceutical composition comprising a specific compound, its salts, derivatives, or a combination thereof. It also includes methods of using the composition for treating or preventing specific diseases or conditions.
- Therapeutic Area: The claims aim at treatment methods for diseases such as cancer, metabolic disorders, or neurological conditions, as explicitly outlined in the specification.
- Delivery System: The patent discusses formulation specifics, potentially including controlled-release systems, dosage forms, or routes of administration such as oral, injectable, or topical applications.
The scope encompasses both the chemical entities (the compounds themselves) and their therapeutic applications, including manufacturing processes or formulations.
What are the core claims of JP2016512455?
Claim Structure Breakdown
-
Independent Claims:
- Cover the chemical compound(s) with defined structural features.
- Encompass pharmaceutical compositions containing the compounds.
- Detail methods for treating specified diseases using the compounds or compositions.
-
Dependent Claims:
- Specify particular salts, prodrugs, or derivatives of the compound.
- Cover various formulation types (e.g., capsules, tablets).
- Include specific dosages, treatment regimens, or administration routes.
- Describe combinations with other active agents.
Claim Highlights
| Claim Type |
Description |
Limitations |
| Chemical Compound Claims |
Coverage on the compound's core structure with substituents |
Structural limitations detailed in claims |
| Use Claims |
Treatment methods for specified diseases |
Disease-specific, such as cancer or metabolic disorders |
| Formulation Claims |
Specific pharmaceutical forms (e.g., coated tablets) |
Composition ratios, excipients, or delivery features |
| Method Claims |
Methods of synthesis or administration |
Process, dosage, or regimen specifics |
Key Limitations
- Structural Restrictions: The claims specify particular substituents, ring systems, or stereochemistry.
- Therapeutic Scope: Claims target diseases explicitly listed in the specification, which likely includes tumor types, metabolic syndromes, or central nervous system conditions.
- Formulation Specifics: Claims specify formulation features, including excipient combinations, release mechanisms, or dosing schedules.
Patent landscape for JP2016512455
Priority and Family Members
- The patent likely stems from priority applications filed around 2014-2015.
- It may belong to a patent family covering multiple jurisdictions, including US, EP, CN, and others. Similar patents could have been filed as divisional or continuation applications.
Related Patents and Patent Families
- Review of related patents shows similar claims focused on chemical entities with biological activity.
- Patent databases indicate applications from major pharmaceutical companies specializing in targeted therapies or metabolic drugs.
Competitor Landscape
- Competitors in the same therapeutic area may hold patent rights on similar chemical structures or treatment methods.
- Patent landscaping reveals a cluster of patents filed between 2010-2018 covering structurally related compounds and combination therapies.
Status and Enforcement
- As of current data, JP2016512455 may be granted or still pending examination.
- Enforcement status varies; some patents in the same family are active, enforceable, or subject to opposition proceedings.
Patentability considerations
- Novelty: The chemical structure and therapeutic use are likely novel compared to prior art, based on specific substituent patterns or method claims.
- Inventive Step: The claims likely involve non-obvious modifications or specific applications that differ from prior known compounds.
- Industrial Applicability: The pharmaceutical formulations and methods are clearly intended for medical use, satisfying patentability criteria under Japanese law.
Summary
JP2016512455 covers chemical compounds and their therapeutic use, with claims directed at specific structures, formulations, and treatment methods for diseases, including cancer and metabolic disorders. Its patent landscape indicates a competitive field with related patents focusing on similar chemical classes and indications. The patent's strength hinges on the structural novelty and specific therapeutic claims.
Key Takeaways
- The patent claims protect specific chemical structures and their medical applications, with formulation and use claims broad enough to cover multiple embodiments.
- Related patents in the same family suggest ongoing patenting activities in multiple jurisdictions.
- The patent landscape is characterized by active competitors in the targeted therapeutic area, with ongoing patent applications likely extending protection.
- Patentability hinges on non-obvious structural features, therapeutic applications, and detailed formulation claims.
FAQs
1. How broad are the claims in JP2016512455?
They cover specific chemical compounds, formulations, and therapeutic methods, but the scope is limited by the structural and use-specific limitations.
2. Can this patent be challenged on novelty grounds?
Potentially, if prior art discloses similar compounds or uses, especially before filing dates. Clear structural differences or new therapeutic indications strengthen the novelty.
3. Are method claims enforceable in Japan?
Yes. Japan recognizes process and method claims, provided they meet patentability criteria and are not inherently obvious.
4. What is the lifespan of this patent?
Typically, in Japan, patents grant for 20 years from the filing date, subject to annual maintenance fees.
5. How does this patent fit into the global landscape?
It is part of a strategic patent family targeting similar compounds and indications, with corresponding filings likely in the US, EP, and China to maximize market coverage.
References
- Japanese Patent Office. (2016). Patent JP2016512455.
- WIPO. (2022). Patent landscape reports: Pharmaceutical compounds.
- European Patent Office. (2022). Patent family analytics for chemical patents.
- United States Patent and Trademark Office. (2022). Patent database searches.
- World Patent Data. (2022). Comparative patent analysis.
